Summary of Significant Accounting Policies (Details) (USD $)	3 Months Ended
	Mar. 31, 2014 Segment	Mar. 31, 2013	Dec. 31, 2013
Summary of Significant Accounting Policies [Line Items]
Goodwill and intangible assets	$ 1,100,000,000		$ 1,100,000,000
Amortization of intangible assets	2,744,000	2,714,000
Revenue from services	1,970,000	3,092,000
Revenue From Transfer Of Intellectual Property	476,000	12,757,000
Total deferred revenue related to other revenues	8,600,000		8,300,000
Allowance for doubtful accounts receivable	(1,566,000)		(1,885,000)
Equity-based compensation expense for continuing operations	3,579,000	5,205,000
Number of reportable segments	2
Pharmaceutical [Member]
Summary of Significant Accounting Policies [Line Items]
Number of operating segments	2
Diagnostics [Member]
Summary of Significant Accounting Policies [Line Items]
Number of operating segments	2
Neovasc [Member]
Summary of Significant Accounting Policies [Line Items]
Revenue from services	$ 100,000	$ 200,000
Minimum [Member]
Summary of Significant Accounting Policies [Line Items]
Intangible assets, estimated useful lives	3 years
Maximum [Member]
Summary of Significant Accounting Policies [Line Items]
Intangible assets, estimated useful lives	10 years